Prolonged Morphine Exposure Induces Increased Firm Adhesion in an in Vitro Model of the Blood–Brain Barrier

Marianne Strazza, Vanessa Pirrone, Brian Wigdahl, Will Dampier, Wei Lin, Rui Feng, Monique E. Maubert, Babette Weksler, Ignacio A. Romero, Pierre‐Olivier Couraud, Michael R. NonnemacherInternational Journal of Molecular Sciences 2016 · DOI

TL;DR

This study investigates how prolonged exposure to morphine affects the blood-brain barrier (BBB) using an in vitro model. They found that morphine doesn't increase BBB "leakiness" but instead upregulates specific cell adhesion molecules, leading to increased firm adhesion of T-cells (CD3+ PBMCs) to the BBB. This suggests a mechanism by which morphine could facilitate immune cell entry into the central nervous system, potentially exacerbating neurological conditions.

What Problem Does This Paper Address?

The blood-brain barrier (BBB) is a crucial protective interface that strictly controls what enters the central nervous system (CNS). While it's known that insults to the BBB can lead to increased permeability and cellular passage, the specific mechanisms by which substances like morphine, a widely used analgesic with known effects on the immune system, alter BBB function are not fully understood. Previous research has shown that short-term morphine exposure can affect tight junction proteins and increase the transmigration of peripheral blood mononuclear cells (PBMCs). However, this paper aims to clarify whether prolonged morphine exposure causes general BBB leakiness or a more specific alteration in cellular adhesion, which could lead to increased immune cell infiltration into the CNS. Understanding these mechanisms is vital for managing pain and addressing neurological complications associated with opioid use, as well as for understanding how drugs of abuse might impact CNS health.

Methods

The researchers utilized an established human brain microvascular endothelial cell (hCMEC/D3) line as their in vitro model of the BBB. This cell line was chosen for its ability to maintain BBB characteristics for several days post-confluence, allowing for prolonged drug exposure studies.

Key methods included:

  • Morphine Exposure: Cells were exposed to varying concentrations of morphine (0.001, 0.01, or 0.1 µM) for extended periods (24, 48, or 72 hours), with morphine being re-administered every 24 hours to maintain consistent drug levels.
  • Permeability Assay: A fluorescein isothiocyanate–dextran (FITC-D) permeability assay was used to assess general BBB leakiness by measuring the passage of a 70 kDa molecule across the cell monolayer. Mannitol was used as a positive control for increased permeability.
  • Gene Expression Analysis (RT-PCR): Real-time quantitative PCR was employed to measure the mRNA levels of key cellular adhesion molecules (CAMs): intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and activated leukocyte cell adhesion molecule (ALCAM).
  • Protein Expression Analysis (Flow Cytometry): Flow cytometry was used to quantify the surface expression of ICAM-1, VCAM-1, and ALCAM on the hCMEC/D3 cells.
  • PBMC Adhesion Assay: Peripheral blood mononuclear cells (PBMCs) were incubated with the treated hCMEC/D3 monolayers to assess the firm adhesion of T-cells (CD3+) and monocytes (CD14+). IL-1β was used as a positive control for enhanced adhesion.
  • Statistical Analysis: Standard statistical methods, including ANOVA and t-tests, were used to analyze the data, with log transformation applied to skewed permeability data. Linear regression was used to correlate CAM expression with PBMC adhesion.

Datasets

Not discussed in the paper. The study utilized cell lines and primary human PBMCs.

Key Insights and Ideas

  • Morphine doesn't cause general BBB "leakiness": A significant finding is that prolonged morphine exposure, even at higher concentrations and durations, did not increase the permeability of the BBB to small molecules like FITC-D. This suggests that morphine's effects are not due to a general breakdown of the barrier.
  • Targeted upregulation of adhesion molecules: Instead of causing widespread damage, morphine specifically upregulates the expression of key cellular adhesion molecules (CAMs) like ICAM-1, VCAM-1, and ALCAM on brain endothelial cells. These molecules are crucial for cell-cell interactions.
  • Increased T-cell adhesion: The upregulation of CAMs directly correlated with an increased firm adhesion of CD3+ T-cells to the BBB. This is a critical insight, as T-cells are key players in immune surveillance and inflammatory responses within the CNS.
  • Differential effects on T-cells vs. monocytes: While T-cell adhesion was significantly increased across various time points, monocyte (CD14+) adhesion was only significantly increased at the longest exposure (72 hours). This suggests a differential impact of morphine on different immune cell types.
  • Potential for accelerated CNS pathology: The study proposes that this increased T-cell adhesion could facilitate their migration into the CNS, potentially accelerating pathological processes in diseases that involve the BBB, such as neuroinflammatory conditions or infections.

Key Results

  • Morphine treatment (0.1 µM for 24, 48, or 72 hours) did not significantly alter the permeability coefficient (Pe) of the hCMEC/D3 monolayer, indicating no general leakiness.
  • mRNA levels of ICAM-1 and VCAM-1 were significantly increased after 24 hours of morphine exposure. VCAM-1 and ALCAM mRNA levels were also increased after 48 hours, while ICAM-1 mRNA levels were unchanged at this time point. After 72 hours, ICAM-1 mRNA levels decreased, while ALCAM mRNA levels remained elevated.
  • Protein expression analysis showed that morphine treatment for 2, 24, 48, and 72 hours significantly increased the number of hCMEC/D3 cells expressing ICAM-1, VCAM-1, and ALCAM on their surface.
  • PBMC adhesion assays revealed that morphine treatment for 24, 48, and 72 hours significantly increased the firm adhesion of CD3+ T-cells to the hCMEC/D3 monolayer.
  • CD14+ monocyte adhesion was significantly increased only after 72 hours of morphine exposure.
  • Linear regression analysis demonstrated a strong correlation between increased surface expression of ICAM-1, VCAM-1, and ALCAM and the increased adhesion of CD3+ T-cells.

Limitations and Future Work

  • In vitro model limitations: The study acknowledges that while the hCMEC/D3 cell line is a valuable model, it is an in vitro system. Future studies could incorporate co-cultures with astrocytes, pericytes, or neurons to better mimic the complex in vivo BBB environment and investigate secondary impacts.
  • Mechanism of CAM upregulation: The exact signaling pathways mediating the observed CAM upregulation are not fully elucidated. The authors suggest exploring the roles of Toll-like receptor 4 (TLR-4) and mu-opioid receptor (MOR) signaling, as these have been implicated in morphine's effects on inflammation and immune cells.
  • Specific CD3+ subpopulation: The study identified increased adhesion of CD3+ T-cells but did not characterize the specific subpopulation of T-cells involved. Further research could focus on identifying these specific T-cell types and their roles.
  • Clinical relevance: While the study uses clinically relevant concentrations of morphine, further in vivo studies are needed to confirm these findings and their implications for human health, particularly in the context of chronic pain management or opioid abuse.
  • Long-term consequences: The study focuses on the immediate effects of prolonged exposure. Investigating the long-term consequences of this increased immune cell infiltration on CNS health and disease progression would be a valuable next step.

Summary updated

Abstract

The blood-brain barrier (BBB) has been defined as a critically important protective barrier that is involved in providing essential biologic, physiologic, and immunologic separation between the central nervous system (CNS) and the periphery. Insults to the BBB can cause overall barrier damage or deregulation of the careful homeostasis maintained between the periphery and the CNS. These insults can, therefore, yield numerous phenotypes including increased overall permeability, interendothelial gap formation, alterations in cytokine and chemokine secretion, and accelerated cellular passage. The current studies expose the human brain microvascular endothelial cell line, hCMEC/D3, to prolonged morphine exposure and aim to uncover the mechanisms underlying alterations in barrier function in vitro. These studies show alterations in the mRNA and protein levels of the cellular adhesion molecules (CAMs) intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and activated leukocyte cell adhesion molecule that correlate with an increased firm adhesion of the CD3⁺ subpopulation of peripheral blood mononuclear cells (PBMCs). Overall, these studies suggest that prolonged morphine exposure may result in increased cell migration into the CNS, which may accelerate pathological processes in many diseases that involve the BBB.
BibTeX
@article{strazza2016prolonged,
  author = {Marianne Strazza and Vanessa Pirrone and Brian Wigdahl and Will Dampier and Wei Lin and Rui Feng and Monique E. Maubert and Babette Weksler and Ignacio A. Romero and Pierre‐Olivier Couraud and Michael R. Nonnemacher},
  title = {{Prolonged Morphine Exposure Induces Increased Firm Adhesion in an in Vitro Model of the Blood–Brain Barrier}},
  journal = {International Journal of Molecular Sciences},
  year = {2016},
  doi = {10.3390/ijms17060916},
}
Figure